Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

HCL Technologies (HCLT.BO)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (Rs) Price Target (Rs) Rating
2022-03-301166.00925.00Sell
2022-07-04984.55950.00Sell
2022-09-29922.65965.00Neutral
2023-01-021039.201060.00Neutral
2023-04-031098.401130.00Neutral
2023-09-291236.201320.00Neutral
2023-10-131255.301350.00Neutral
2024-01-041419.651540.00Neutral
2024-01-131543.001600.00Neutral
2024-04-291387.101520.00Neutral
2024-06-281459.601500.00Neutral
2024-10-151870.051950.00Neutral
2025-01-021971.402250.00Buy
2025-02-201688.202220.00Buy
2025-03-251626.252030.00Buy
2025-04-221480.101900.00Buy

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.